Exportación Completada — 

The Memory Alteration Test Discriminates between Cognitively Healthy Status, Mild Cognitive Impairment and Alzheimer’s Disease

Descripción del Articulo

Background/Aims: Dementia is a worldwide public health problem and there are several diagnostic tools for its assessment. The aim of this study was to evaluate the performance of the Memory Alteration Test (M @ T) to discriminate between patients with early Alzheimer’s disease (AD), patients with am...

Descripción completa

Detalles Bibliográficos
Autores: Custodio, Nilton, Lira, David, Herrera Perez, Eder, Nuñez del Prado, Liza, Parodi García, José Francisco, Guevara Silva, Erik, Castro Suarez, Sheila, Montesinos, Rosa, Cortijo, Patricia
Formato: artículo
Fecha de Publicación:2014
Institución:Universidad de San Martín de Porres
Repositorio:USMP-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.usmp.edu.pe:20.500.12727/1539
Enlace del recurso:https://hdl.handle.net/20.500.12727/1539
https://doi.org/10.1159/000365280
Nivel de acceso:acceso abierto
Materia:Demencia
Diagnóstico diferencial
Trastornos de la memoria
Enfermedad de Alzheimer
616.8 - Enfermedades del sistema nervioso y trastornos mentales
https://purl.org/pe-repo/ocde/ford#3.02.00
Descripción
Sumario:Background/Aims: Dementia is a worldwide public health problem and there are several diagnostic tools for its assessment. The aim of this study was to evaluate the performance of the Memory Alteration Test (M @ T) to discriminate between patients with early Alzheimer’s disease (AD), patients with amnestic mild cognitive impairment (a-MCI), and subjects with a cognitively healthy status (CHS). Methods: The discriminative validity was assessed in a sample of 90 patients with AD, 45 patients with a-MCI, and 180 subjects with CHS. Clinical, functional, and cognitive studies were independently performed in a blinded fashion and the gold standard diagnosis was established by consensus on the basis of these results. The test performance was assessed by means of a receiver operating characteristic curve analysis as area under the curve (AUC). Results: M @ T mean scores were 17.7 (SD = 5.7) in AD, 30.8 (SD = 2.3) in a-MCI, and 44.5 (SD = 3.1) in CHS. A cutoff score of 37 points had a sensitivity of 98.3% and a specificity of 97.8% to differentiate a-MCI from CHS (AUC = 0.999). A cutoff score of 27 points had a sensitivity of 100% and a specificity of 98.9% to differentiate mild AD from a-MCI and from CHS (AUC = 1.000). Conclusions: The M @ T had a high performance in the discrimination between early AD, a-MCI and CHS.
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).